BEAM - Financial Reports List - Beam Therapeutics Inc. - IntrinsicAlpha

Beam Therapeutics Inc. BEAM

Healthcare - Biotechnology - NASDAQ - US

$ 18.79

7.29 %

$ 1.88 B

Market Cap

-3.98

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-90.49%	-63.27%	-75.30%
Annual Report	FY	10-K	2024-12-31	-83.18%	-184.28%	-135.47%
Quarterly Report	Q3	8-K	2024-09-30	-17.01%	-0.60%	1.63%
Quarterly Report	Q2	8-K	2024-06-30	-41.48%	-10.00%	-2.69%
Quarterly Report	Q1	8-K	2024-03-31	-69.39%	-17.42%	-5.26%
Quarterly Report	Q4	8-K	2023-12-31	1478.04%	472.36%	249.30%
Annual Report	FY	10-K	2023-12-31	520.01%	49.72%	47.86%
Quarterly Report	Q3	8-K	2023-09-30	8.82%	12.31%	-18.58%
Quarterly Report	Q2	8-K	2023-06-30	20.80%	-70.67%	-24.62%
Quarterly Report	Q1	8-K	2023-03-31	187.10%	-52.25%	-29.78%

1